Ticker Scorecard - ETNB Basics Company: 89bio, Inc. Common Stock IPO Date: November 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.29B Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 3.41% Avg Daily Range (30 D): $0.32 | 3.93% Avg Daily Range (90 D): $0.27 | 3.25% Institutional Daily Volume Avg Daily Volume: .73M Avg Daily Volume (30 D): 2.48M Avg Daily Volume (90 D): 1.27M Trade Size Avg Trade Size (Sh.): 99 Avg Trade Size (Sh.) (30 D): 118 Avg Trade Size (Sh.) (90 D): 100 Institutional Trades Total Inst.Trades: 1,008 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.39M Avg Inst. Trade (90 D): $1.31M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.49M Avg Closing Trade (30 D): $1.82M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 209.55K     News Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Nov 29, 2024 @ 6:30 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: N/A Nov 13, 2024 @ 4:58 AM 89bio, Inc. Announces Upsized Pricing of $125.0 Mi... Source: 89Bio, Inc. Jun 14, 2024 @ 8:05 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: 89bio, Inc. May 22, 2024 @ 8:05 PM 89bio to Present 48-Week Data from ENLIVEN Phase 2... Source: 89bio, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.91 $-1.39 $-.48 Diluted EPS $-2.91 $-1.39 $-.48 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -288.96M $ -149.07M $ -47.97M Operating Income / Loss $ -303.86M $ -151.94M $ -53.44M Cost of Revenue $ $ $ Net Cash Flow $ -160.52M $ -120.81M $ -5.36M PE Ratio